Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miquel Navasa

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|May 6, 2003
Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantationVíctor Vargas, Antoni Rimola, Teresa Casanovas, et al.
World Journal of Gastroenterology|September 29, 2006
Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantationGraciela Martínez-Palli, Federico P Gómez, Joan A Barberà, et al.
Surgery|December 17, 2008
Optimization of liver grafts in liver retransplantation: a European single-center experienceJosep Martí, Ramón Charco, Joana Ferrer, et al.
Journal of Hepatology|April 8, 2014
Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantationZoe Mariño, Laura Mensa, Gonzalo Crespo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantationCarlos Cervera, Domingo Balderramo, Belén Suárez, et al.
Gastroenterology|May 9, 2007
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled studyJosé A Carrión, Miquel Navasa, Montserrat García-Retortillo, et al.
Journal of Hepatology|February 27, 2018
The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list compositionGonzalo Crespo, Núria Trota, Maria-Carlota Londoño, et al.
Clinical Transplantation|April 23, 2016
Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphismMaria J Citores, Sofia Pérez-Pulgar, Ana Duca, et al.
Plos One|January 10, 2013
Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteinsGeorge Koutsoudakis, Jakub Dragun, Sofia Pérez-Del-Pulgar, et al.
Gastroenterology|April 19, 2006
Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantationMaria-Carlota Londoño, Mónica Guevara, Antoni Rimola, et al.
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Transplant International : Official Journal of the European Society for Organ Transplantation|May 6, 2003
Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantationVíctor Vargas, Antoni Rimola, Teresa Casanovas, et al.
World Journal of Gastroenterology|September 29, 2006
Sustained low diffusing capacity in hepatopulmonary syndrome after liver transplantationGraciela Martínez-Palli, Federico P Gómez, Joan A Barberà, et al.
Surgery|December 17, 2008
Optimization of liver grafts in liver retransplantation: a European single-center experienceJosep Martí, Ramón Charco, Joana Ferrer, et al.
Journal of Hepatology|April 8, 2014
Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantationZoe Mariño, Laura Mensa, Gonzalo Crespo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantationCarlos Cervera, Domingo Balderramo, Belén Suárez, et al.
Gastroenterology|May 9, 2007
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled studyJosé A Carrión, Miquel Navasa, Montserrat García-Retortillo, et al.
Journal of Hepatology|February 27, 2018
The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list compositionGonzalo Crespo, Núria Trota, Maria-Carlota Londoño, et al.
Clinical Transplantation|April 23, 2016
Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphismMaria J Citores, Sofia Pérez-Pulgar, Ana Duca, et al.
Plos One|January 10, 2013
Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteinsGeorge Koutsoudakis, Jakub Dragun, Sofia Pérez-Del-Pulgar, et al.
Gastroenterology|April 19, 2006
Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantationMaria-Carlota Londoño, Mónica Guevara, Antoni Rimola, et al.
Pageof 11